Strokes in Younger Adults Are a Warning for Prevention Policy

Stroke prevention is still often framed around the risks of older age. Yet the conditions that lead to a stroke can develop decades earlier, while adults in their 20s, 30s, and 40s may have little reason to think they need cardiovascular care. A new population-based study found that stroke incidence among adults ages 20 to 54 in a five-county region of Ohio and Kentucky rose from 33.9 to 62.18 cases per 100,000 person-years between 1993-1994 and 2020. Incidence fell among older adults during the same period. The study does not establish a national trend or explain precisely what caused the increase. It does show why prevention efforts cannot assume that serious cardiovascular events will wait until later in life.

The increase was driven largely by ischemic strokes, which occur when blood flow to the brain is blocked. Among younger adults in the study, ischemic stroke incidence rose from 23.8 to 47.3 cases per 100,000 person-years. Hypertension, diabetes, atrial fibrillation, and documented substance use also became more common among younger patients who had strokes. Those findings should inform prevention, but they do not prove that any one factor caused the increase. The researchers measured risk factors among people who had strokes, without comparable data showing how those factors changed among people who did not. Diagnostic practices also changed over nearly three decades. Federal policy should respond to established cardiovascular risks while supporting research that can explain why stroke incidence is moving in the wrong direction for this age group.

The country already spends heavily on the consequences of cardiovascular disease. According to the Centers for Disease Control and Prevention, 120 million Americans have high blood pressure, while cardiovascular disease costs the healthcare system $233.3 billion annually and accounts for another $184.6 billion in lost productivity. Those figures cover cardiovascular disease broadly, not strokes among younger adults specifically. They nevertheless illustrate why early risk detection deserves attention beyond the clinical setting. A stroke during working age can affect employment, family income, and the need for rehabilitation or ongoing care for years. The study found that the 30-day case fatality rate among younger adults declined from 11.7 percent to 9.4 percent over the study period, making long-term outcomes an important part of the policy discussion.

Finding a risk factor is useful only if someone can help a patient address it. A blood pressure reading at an occasional appointment does little if the patient cannot obtain follow-up care, start treatment when needed, or determine whether that treatment is working. CDC-funded programs already support electronic health records that identify patients with risk factors, care teams that include pharmacists and community health workers, and blood pressure measurement outside the clinic. From 2018 to 2022, health systems working with funded states improved blood pressure control rates by 5 percent, according to CDC. That experience offers a practical model: identify a risk, connect the patient to care, and measure whether the risk comes under control. For younger adults who may not routinely see a primary care provider, each step needs to work across different points of entry into the health system.

Congress could build on that infrastructure without creating a separate national stroke program for younger adults. One approach would be to direct a portion of CDC heart disease and stroke prevention funding toward demonstration projects focused on adults under 55, especially in communities with high rates of uncontrolled hypertension or limited access to primary care. Grant recipients could test outreach through community health centers, pharmacies, and other accessible settings, then report how many patients receive follow-up after an elevated reading and how many achieve sustained blood pressure control. The requirement to report outcomes is essential. In fiscal year 2025, CDC awarded about $116 million for state, local, tribal, and health system work on heart disease and stroke risk factors. Congress should use future funding decisions to learn which approaches reach younger adults and improve control, rather than assuming that additional screening alone will reduce strokes.

Federal research should proceed alongside that work. The new study covers one region, six study periods, and adults spanning more than three decades of age. NIH and CDC could support surveillance that examines narrower age groups, geographic differences, and changes in stroke diagnosis over time. That would help establish whether the increase observed in Ohio and Kentucky appears elsewhere and which populations face the greatest risk. It would also help policymakers distinguish between plausible explanations and demonstrated causes before directing resources toward any one exposure. Better data would make prevention programs more precise, but uncertainty about the cause of this trend is no reason to defer treatment of hypertension and other known risks.

Existing federal efforts provide a starting point for both prevention and care after a stroke. CDC's WISEWOMAN program offers cardiovascular screening and referrals to eligible women ages 35 to 64, and Million Hearts focuses on blood pressure control, cholesterol management, and other established prevention priorities. The Paul Coverdell National Acute Stroke Program works to improve care from the first symptoms through discharge and recovery. Over the next 12 to 24 months, stakeholders should watch whether federal and state programs can better connect these efforts: reaching younger adults before an event, tracking whether identified risks are treated, and improving follow-up for those who survive a stroke.

Stroke remains less common in younger adults than in older adults, and one regional study cannot establish the scale of the national problem. It is enough, however, to challenge a prevention system that too often waits until cardiovascular risk has already become cardiovascular disease.